Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Board/Management Information 2020

Jan 28, 2020

61842_rns_2020-01-28_f2d29a73-627c-42df-b7fd-6d67fee1204f.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [59 x 56] intentionally omitted <==

SOLARA Ac..tiive Pt1a1.r1r ai S<!iences

CQ.r;n,:nJ.mic:a1it"®n Ad.dress: Solara Active Pharma Sciences Limited Batra Centre No. 28, Sardar Patel Road. Post Box 2630 Guindy, Chennai - 600 032, India Tel : +91 44 43446700, 22207500 Fax: +91 44 22350278

January 28, 2020

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 541540 Scrip Code: SOLARA Dear Sirs,

Subject: Regulation 29 of the Listing Regulations - Board Meeting Intimation

We hereby inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 06, 2020 inter alia, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31, 2019.

In accordance with the Company's Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from January 1, 2020 till 48 hours after the announcement of financial results i.e. up to February 08, 2020 (both days inclusive).

This is for your information and appropriate dissemination.

Thanking you,

Yours faithfully, For Solara Active Pharma Sciences Limited

==> picture [123 x 41] intentionally omitted <==

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942